Equillium News

Buy Rating Affirmed for Equillium on Strong Itolizumab Data and Promising EQ101 Phase 2 Prospects

TipRanksMay 8 18:30

Buy Rating Affirmed for Equillium on Strong Clinical Data and Potential Financial Upsides

TipRanksApr 3 13:45

Equillium Analyst Ratings

BenzingaApr 2 20:54

Buy Rating Reaffirmed for Equillium on Strong Itolizumab Trial Results and Positive Financial Outlook

TipRanksApr 2 18:27

Buy Rating Affirmed for Equillium Amid Promising Clinical Trials and Potential Financial Upsides

TipRanksMar 27 14:55

HC Wainwright & Co. Maintains Buy on Equillium, Lowers Price Target to $4

BenzingaDec 26, 2023 19:22

Equillium Analyst Ratings

BenzingaDec 26, 2023 19:21

Equillium's Stock Buy Rating Affirmed Amid Pipeline Progress and Clinical Trial Advancements

TipRanksDec 26, 2023 19:15

Leerink Partners Sticks to Their Buy Rating for Equillium (EQ)

TipRanksDec 25, 2023 13:36

Equillium Analyst Ratings

BenzingaNov 14, 2023 00:23

Equillium's Promising Pipeline and Financial Stability: A Comprehensive Analysis and Buy Rating Recommendation

TipRanksNov 10, 2023 19:32

Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Hims & Hers Health (HIMS) and Axsome Therapeutics (AXSM)

TipRanksOct 25, 2023 14:30

HC Wainwright & Co. Reiterates Buy on Equillium, Maintains $5.5 Price Target

BenzingaAug 14, 2023 18:24

Equillium Analyst Ratings

BenzingaAug 14, 2023 18:23

HC Wainwright & Co. Reiterates Buy on Equillium, Maintains $5.5 Price Target

BenzingaMay 15, 2023 18:33

Equillium (EQ) Receives a Rating Update From a Top Analyst

TipRanksMay 15, 2023 18:06

HC Wainwright & Co. Maintains Buy on Equillium, Lowers Price Target to $5.5

BenzingaMay 1, 2023 18:30

Analysts' Top Healthcare Picks: Equillium (EQ), Pliant Therapeutics (PLRX)

TipRanksMay 1, 2023 18:21

SVB Securities Reaffirms Their Buy Rating on Equillium (EQ)

TipRanksMar 28, 2023 18:07

Stifel Nicolaus Sticks to Its Buy Rating for Equillium (EQ)

TipRanksMar 27, 2023 13:46